Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2020

01-06-2020 | Radiotherapy | Editorial

SEOR recommendations on the use of protons

Authors: M. Lloret-Saez-Bravo, J. Giralt-L de Sagredo, J. Contreras-Martinez, C. Ferrer-Albiach

Published in: Clinical and Translational Oncology | Issue 6/2020

Login to get access

Excerpt

Radiotherapy is one of the fundamental strategies in the treatment of cancer that is used in more than 60% of patients with this disease. It can be used with curative intention or to alleviate symptoms, always trying to minimize toxicity in healthy tissues. …
Literature
1.
Herranz E. I Encuentro complutense para la divulgación en Física Nuclear y de partículas. 2008.
2.
Doyen J, Tuan Falk A, Floquet V, Hérault J, Hannoun-Lévi J-M. Proton beams in cancer treatments: clinical outcomes and dosimetric comparisons with photon therapy. Cancer Treat Rev. 2016;43:104–12.CrossRef
3.
Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2328–38.CrossRef
4.
Turcotte LM, Whitton JA, Friedman DL, et al. Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort. J Clin Oncol. 2015;33:3568–78.CrossRef
5.
Yock TI, Yeap BY, Ebb DH, et al. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016;17(3):287–98.CrossRef
6.
7.
Langendijk JA, et al. Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach. Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands. Radiother Oncol. 2013;107:267–73.CrossRef
8.
9.
Proton Radiotherapy. Horizon scanning report. The Hague: Health Council of the Netherlands, 2009; publication no. 2009/17E. ISBN: 978-90-5549-786-7
10.
11.
Grau M. La protonterapia en el tratamiento del cáncer. Actualización. Barcelona: Ministerio de Sanidad, Servicios Sociales e Igualdad. Agència de Qualitat i Avaluació Sanitàries de Catalunya. Departament de Salut. Generalitat de Catalunya; 2018 (Informes de Evaluación de Tecnologías Sanitarias). © 2018 Ministerio de Sanidad, Servicios Sociales e Igualdad.
12.
Metadata
Title
SEOR recommendations on the use of protons
Authors
M. Lloret-Saez-Bravo
J. Giralt-L de Sagredo
J. Contreras-Martinez
C. Ferrer-Albiach
Publication date
01-06-2020
Publisher
Springer International Publishing
Keyword
Radiotherapy
Published in
Clinical and Translational Oncology / Issue 6/2020
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-019-02194-9

Other articles of this Issue 6/2020

Clinical and Translational Oncology 6/2020 Go to the issue

Research Article

Detection of incident breast and colorectal cancer cases from an administrative healthcare database in Catalonia, Spain

Research Article

Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer

Editorial

Ethical commitment of Spanish oncologists to patients with prostate cancer: reflections on the statements of the new ASTRO/AUA guideline (2019 guideline amendment)

Research Article

Detection of novel mitochondrial mutations in cytochrome C oxidase subunit 1 (COX1) in patients with familial adenomatous polyposis (FAP)

Research Article

Prognostic role of interleukin-6 in renal cell carcinoma: a meta-analysis

Research Article

Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits